Concepedia

David Sullivan

DS

Statistics

Publications

135

Citations

11.2K

H-Index

57

Active since

1982

Affiliations

Royal Prince Alfred Hospital(Current)

The University of Sydney

National Health and Medical Research Council

The University of Western Australia

The University of Melbourne

David Sullivan is an author at Royal Prince Alfred Hospital specializing in medicine, cardiovascular disease, and pharmacology.

ORCID

Publications per year

1982–2025

135

Publications

135

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

Frederick J. Raal, Evan A. Stein, Robert Dufour et al. · The Lancet · 2014 · 751 citations

, , +17

Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance

Erik S.G. Stroes, David Colquhoun, David Sullivan et al. · Journal of the American College of Cardiology · 2014 · 527 citations · Full text

, , +14

Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients

David Sullivan, Anders Olsson, Robert C. Scott et al. · JAMA · 2012 · 448 citations

, , +17

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

Timothy M. E. Davis, R. Ting, James D. Best et al. · Diabetologia · 2010 · 365 citations · Full text

, , +15

Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients

Mika Hilvo, Peter J. Meikle, Eva Ringdal Pedersen et al. · European Heart Journal · 2019 · 305 citations · Full text

, , +17

1–5 of 135